Literature DB >> 25329189

Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications.

Ying Wang1, Xiaodong Chen1, Wei Cao1, Yufang Shi2.   

Abstract

Mesenchymal stem cells (MSCs) are multipotent stromal cells that exist in many tissues and are capable of differentiating into several different cell types. Exogenously administered MSCs migrate to damaged tissue sites, where they participate in tissue repair. Their communication with the inflammatory microenvironment is an essential part of this process. In recent years, much has been learned about the cellular and molecular mechanisms of the interaction between MSCs and various participants in inflammation. Depending on their type and intensity, inflammatory stimuli confer on MSCs the ability to suppress the immune response in some cases or to enhance it in others. Here we review the current findings on the immunoregulatory plasticity of MSCs in disease pathogenesis and therapy.

Entities:  

Mesh:

Year:  2014        PMID: 25329189     DOI: 10.1038/ni.3002

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  84 in total

Review 1.  Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.

Authors:  Sudhir H Ranganath; Oren Levy; Maneesha S Inamdar; Jeffrey M Karp
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

2.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

Authors:  Amelia Bartholomew; Cord Sturgeon; Mandy Siatskas; Karen Ferrer; Kevin McIntosh; Sheila Patil; Wayne Hardy; Steve Devine; David Ucker; Robert Deans; Annemarie Moseley; Ronald Hoffman
Journal:  Exp Hematol       Date:  2002-01       Impact factor: 3.084

3.  Umbilical cord-derived mesenchymal stem cells instruct dendritic cells to acquire tolerogenic phenotypes through the IL-6-mediated upregulation of SOCS1.

Authors:  Yinan Deng; Shuhong Yi; Guoying Wang; Jintao Cheng; Yingcai Zhang; Wenjie Chen; Yan Tai; Shaohong Chen; Guihua Chen; Wei Liu; Qi Zhang; Yang Yang
Journal:  Stem Cells Dev       Date:  2014-05-27       Impact factor: 3.272

Review 4.  Bone marrow mesenchymal stem cells and TGF-β signaling in bone remodeling.

Authors:  Janet L Crane; Xu Cao
Journal:  J Clin Invest       Date:  2014-02-03       Impact factor: 14.808

5.  Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients.

Authors:  Zheng Zhang; Hu Lin; Ming Shi; Ruonan Xu; Junliang Fu; Jiyun Lv; Liming Chen; Sa Lv; Yuanyuan Li; Shuangjie Yu; Hua Geng; Lei Jin; George K K Lau; Fu-Sheng Wang
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

6.  A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.

Authors:  Ruth S Waterman; Suzanne L Tomchuck; Sarah L Henkle; Aline M Betancourt
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

7.  Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis.

Authors:  Gabriela Constantin; Silvia Marconi; Barbara Rossi; Stefano Angiari; Laura Calderan; Elena Anghileri; Beatrice Gini; Simone Dorothea Bach; Marianna Martinello; Francesco Bifari; Mirco Galiè; Ermanna Turano; Simona Budui; Andrea Sbarbati; Mauro Krampera; Bruno Bonetti
Journal:  Stem Cells       Date:  2009-10       Impact factor: 6.277

8.  Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression.

Authors:  Guangwen Ren; Juanjuan Su; Liying Zhang; Xin Zhao; Weifang Ling; Andrew L'huillie; Jimin Zhang; Yongqing Lu; Arthur I Roberts; Weizhi Ji; Huatang Zhang; Arnold B Rabson; Yufang Shi
Journal:  Stem Cells       Date:  2009-08       Impact factor: 6.277

9.  Mesenchymal stem cells.

Authors:  A I Caplan
Journal:  J Orthop Res       Date:  1991-09       Impact factor: 3.494

10.  Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species.

Authors:  J Su; X Chen; Y Huang; W Li; J Li; K Cao; G Cao; L Zhang; F Li; A I Roberts; H Kang; P Yu; G Ren; W Ji; Y Wang; Y Shi
Journal:  Cell Death Differ       Date:  2013-10-25       Impact factor: 15.828

View more
  449 in total

Review 1.  Overcoming immunoregulatory plasticity of mesenchymal stem cells for accelerated clinical applications.

Authors:  Nayoun Kim; Seok-Goo Cho
Journal:  Int J Hematol       Date:  2015-12-11       Impact factor: 2.490

2.  Enabling mesenchymal stromal cell immunomodulatory analysis using scalable platforms.

Authors:  Evelyn Kendall Williams; José R García; Robert G Mannino; Rebecca S Schneider; Wilbur A Lam; Andrés J García
Journal:  Integr Biol (Camb)       Date:  2019-04-01       Impact factor: 2.192

3.  Effect of Timing and Complement Receptor Antagonism on Intragraft Recruitment and Protolerogenic Effects of Mesenchymal Stromal Cells in Murine Kidney Transplantation.

Authors:  Federica Casiraghi; Marta Todeschini; Nadia Azzollini; Paolo Cravedi; Paola Cassis; Samantha Solini; Sonia Fiori; Cinzia Rota; Aida Karachi; Camillo Carrara; Marina Noris; Norberto Perico; Giuseppe Remuzzi
Journal:  Transplantation       Date:  2019-06       Impact factor: 4.939

Review 4.  Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities.

Authors:  Jacques Galipeau; Luc Sensébé
Journal:  Cell Stem Cell       Date:  2018-06-01       Impact factor: 24.633

5.  Mesenchymal Stem Cells: Miraculous Healers or Dormant Killers?

Authors:  Abbas Ghaderi; Shabnam Abtahi
Journal:  Stem Cell Rev Rep       Date:  2018-10       Impact factor: 5.739

6.  Hypoxic Conditioned Medium From Human Adipose-Derived Stem Cells Promotes Mouse Liver Regeneration Through JAK/STAT3 Signaling.

Authors:  Sang Chul Lee; Hye Jin Jeong; Sang Kuon Lee; Say-June Kim
Journal:  Stem Cells Transl Med       Date:  2016-04-21       Impact factor: 6.940

Review 7.  Nanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia.

Authors:  Chengyi Tu; Subhamoy Das; Aaron B Baker; Janeta Zoldan; Laura J Suggs
Journal:  ACS Nano       Date:  2015-04-10       Impact factor: 15.881

8.  Generation and characterization of transgenic mouse mesenchymal stem cell lines expressing hIGF-1 or hG-CSF.

Authors:  Gabrielle V M Gonçalves; Daniela N Silva; Rejane H Carvalho; Bruno S F Souza; Kátia Nunes da Silva; Juliana F Vasconcelos; Bruno D Paredes; Carolina K V Nonaka; Ricardo Ribeiro-Dos-Santos; Milena B P Soares
Journal:  Cytotechnology       Date:  2017-09-02       Impact factor: 2.058

9.  Umbilical Cord Blood Mesenchymal Stem Cells Enhance Lipopolysaccharide-Induced IL-10 and IL-37 Production in THP-1 Cells.

Authors:  Ting Zhou; Yan Sun; Yanli Wang; Xiaobing Chen; Luo Zhuo; Lin Bu; Suo Xu; Jiayan Han; Xiaomin Li; Jiaxin Shi
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

Review 10.  Mesenchymal Stromal Cells in Animal Bleomycin Pulmonary Fibrosis Models: A Systematic Review.

Authors:  Nadim Srour; Bernard Thébaud
Journal:  Stem Cells Transl Med       Date:  2015-10-22       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.